Sekine, Y., Nakayama, H., Miyazawa, Y., Kato, H., Furuya, Y., Arai, S., . . . Suzuki, K. (2018). Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism. Oncol Lett.
Chicago Style CitationSekine, Yoshitaka, et al. "Simvastatin in Combination With Meclofenamic Acid Inhibits the Proliferation and Migration of Human Prostate Cancer PC-3 Cells Via an AKR1C3 Mechanism." Oncol Lett 2018.
Cita MLASekine, Yoshitaka, et al. "Simvastatin in Combination With Meclofenamic Acid Inhibits the Proliferation and Migration of Human Prostate Cancer PC-3 Cells Via an AKR1C3 Mechanism." Oncol Lett 2018.
Atenció: Aquestes cites poden no estar 100% correctes.